This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Christine Rückert, PhD
Senior Scientist at CureVac AG


Christine Rueckert has joined the Research and Development team of CureVac as a scientist in 2016. She develops mRNA delivery technology for prophylactic and therapeutic vaccine applications in the department Product Design and Formulation.

Previously, she had postdoctoral and Research Associate positions at the University of Virgina (USA), Charité Berlin, Freie Universitaet Berlin, Helmholtz Centre for Infection Research Braunschweig (Germany) where she conducted research in biophysics, cell biology and immunology. She is an author of 23 research publications.

She studied biophysics at the Humboldt-Universitaet zu Berlin and molecular biology/immunology at Imperial College, London, and received her doctoral degree in Experimental Biophysics from the Humboldt-Universitaet zu Berlin.

Agenda Sessions

  • mRNA Delivery Strategies

    On Demand
  • mRNA Delivery Strategies

    On Demand
  • mRNA Extra-Hepatic Delivery and Development Progress


Speakers at this event